Hypersensitivity reactions related to oxaliplatin (OHP)
2003 · British Journal of Cancer · 138 citations
https://doi.org/10.1038/sj.bjc.6601155
A
Andrea Antonuzzo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
2.1K
Citations
23
h-index
40
i10-index
Andrea Antonuzzo is an academic researcher from Fondazione IRCCS Istituto Nazionale dei Tumori. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Lung Cancer Research Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 23, co-authored 132 publications.
ORCID: 0000-0002-1384-4953Papers by this author
worksInterprofessional spiritual care in oncology: a literature review
2019 · ESMO Open · 130 citations
https://doi.org/10.1136/esmoopen-2018-000465
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months
2017 · Experimental Hematology and Oncology · 67 citations
https://doi.org/10.1186/s40164-017-0067-4
First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study
2008 · British Journal of Cancer · 8 citations
https://doi.org/10.1038/sj.bjc.6604187
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
2021 · ESMO Open · 5 citations
https://doi.org/10.1016/j.esmoop.2021.100293
A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma
2018 · Tumori Journal · 3 citations
https://doi.org/10.1177/0300891618778952
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat